Researchers are making advances in chemotherapy, immunotherapy, radiotherapy, and other techniques.
Mesothelioma, a cancer that invades the wall lining of the lungs and other internal organs, is a particularly difficult type of cancer to treat. Almost universally related to the inhalation of asbestos particles, treatment of advanced stages of the disease is largely palliative. Palliative health care refers to the focus of relieving symptoms and pain […]
Esophageal Stents As a Palliative Care Measure for Mesothelioma Read More »
It’s clear that the human immune system is really no match for cancer. At least, this has been the conventional wisdom for quite some time. Yet, scientists know the immune system fights cancer, and therefore have hypothesized that if we can optimize our body’s defense system it could potentially be able to fight tumors. In
Making Patients Sicker May Help Them Fight Cancer Read More »
Personalizing cancer treatments has long been heralded as a way to improve survivor rates and limit detrimental side effects. This is largely due to a particular patient’s level of sensitivity to the drugs prescribed. In an effort to better predict this sensitivity, researchers at MIT went digging through our DNA. Presently, there are two tactics
Using Genes to Predict Responsiveness to Cancer Drugs Read More »
The International Mesothelioma Interest Group (IMIG) meets on a yearly basis to discuss cutting-edge news related to the deadly cancer known as malignant mesothelioma. Over the past few years, the IMIG has become increasingly confident and optimistic about current and upcoming mesothelioma treatment processes. Key factors related to effective treatment of mesothelioma that the IMIG
Experts Optimistic About the Progression Of Mesothelioma Treatment Read More »
Researchers have published two studies that show Alimta and Paraplatin form a promising combination for patients with mesothelioma. In September 2007 at the 12th World Conference on Lung Cancer, scientists presented a study on the combination of Alimta and Paraplatin as a treatment option for patients with malignant mesothelioma. The first study had an overall
Two Studies on Alimta and Paraplatin Read More »
Stand Up to Cancer, a charity that will provide funding for cancer research is set to launch this summer through a collaboration with major television networks, entertainers and prominent cancer researchers. The initiative will support cancer research by providing money for cancer studies including high-risk high-impact research proposals often not supported by conventional funding sources.
New Cancer Initiative Set for Launch Read More »
Oncolytics Biotech presented data that indicates malignant mesothelioma cells are sensitive to certain viruses. Their presentation titled “Combination Immunotherapy and Oncolytics Virotherapy for the Treatment of Malignant Mesothelioma” discussed in vitro data showing mesothelioma cells could be suitable targets for reoviruses which could then attack and compromise them. The company currently has 7 ongoing phase
Data Supports Further Investigation of Mesothelioma Virotherapy Read More »
Piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), has shown anti-tumoral activity which is amplified when combined with Cisplatin. Researchers used two mesothelioma cell lines and treated cells with piroxicam and cisplatin alone then combined the two treatments. Cell growth was significantly limited in both lines and treatment with either agent appeared to disrupt cell cycle phase
Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells Read More »
A study in the newest issue of The Lancet concluded that adding chemotherapy to other treatments given to mesothelioma patients does not appear to affect survival or quality of life. Patients suffering from malignant pleural mesothelioma were separated into three groups. The first was given a weekly injection of vinorelbine while the second was a
Study: Disappointing Results for Mesothelioma and Chemotherapy Read More »
The Molcule of the Day blog has an entry today on doxorubicin, a chemotherapy agent. Like many chemotherapy drugs, doxorubicin interferes with DNA and stops cells from replicating. Doxorubicin is used for treatment of many cancers, and has been around for decades.
Doxorubicin – chemotherapy agent Read More »